Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor
- 1 December 2000
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 48 (5) , 1519-1528
- https://doi.org/10.1016/s0360-3016(00)01358-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Two erbB-4 transcripts are expressed in normal breast and in most breast cancersOncogene, 1998
- Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cellsOncogene, 1998
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastomaInternational Journal of Cancer, 1994
- Increasing Epidermal Growth Factor Receptor Expression in Human Melanocytic Tumor ProgressionJournal of Investigative Dermatology, 1992
- Growth factor signaling: Where is the specificity?Cell, 1992
- The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cellsBreast Cancer Research and Treatment, 1991
- EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCERThe Lancet, 1989
- Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neuJournal of Steroid Biochemistry, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987